Vyvanse contains d-amphetamine (or lisdexamfetamine) that is confusable in effects to Ritalin and Adderall. It is a plan II drug—considered insecure with prospective for severe scientific discipline or carnal dependence. Cravings for Vyvanse lead to drug-seeking behavior.
NEW YORK (Reuters Health) - The stimulant drug Vyvanse improves attention deficit upset disorder (ADHD) in adolescents occurrence as early as the premier calendar week of treatment, accordant to a new study. “We saw a 50 percent improvement in symptoms” compared with placebo, Dr. Childress given her group’s findings this week at the american psychiatrical connexion reference book meeting in New Orleans. “Vyvanse improved symptoms of inattention, hyperactivity and impulsivity compared to placebo,” she noted.
Stimulant medications, for example, increment levels of certain neurotransmitters (brain chemicals) to improve concentration and centring and to trim hyperactive and impulsive behavior. Lisdexamfetamine (Vyvanse) and mixed salts amphetamine (Adderall) are two hot stimulants used to happening ADHD. Both drugs can be effective, but the differences in some of their features may sort one of them a more appealing choice for you. The FDA approved Adderall in 1996, and Vyvanse has been open since 2007.